Roth MKM analyst Jeff Martin lowered the firm’s price target on TransAct Technologies to $6 from $10 and keeps a Buy rating on the shares. The company’s FST should be able to gain traction in the coming quarters and accelerate the pace of recurring revenue, but the elevator-down move in FST from the loss of 7-Eleven will weigh on shares until there is evidence of improved pipeline conversions for BOHA! terminals, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TACT:
- TransAct Technologies reports preliminary Q1 EPS (10c), consensus (15c)
- TransAct Technologies Offers Clarity on Financial Results
- TransAct Technologies price target lowered to $9 from $10 at Craig-Hallum
- TransAct Technologies sees FY24 revenue $53M-$58M, two estimates $57.4M
- TransAct Technologies reports Q4 EPS (1c), two estimates (3c)